MultipleMAGE-Agenes as surveillance marker for the detection of circulating tumor cells in patients with ovarian cancer

Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas

(2013) Anne-Katrin Zimmermann et al.   VIRCHOWS ARCHIV

Progress in circulating tumor cell capture and analysis: implications for cancer management

(2012) Marija Balic et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125

(2012) Florian Weiland et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Circulating tumor cells in breast cancer: A tool whose time has come of age

(2011) Ramona F Swaby et al.   BMC Medicine

Circulating Tumor Cell Isolation and Diagnostics: Toward Routine Clinical Use

(2011) A. van de Stolpe et al.   CANCER RESEARCH

Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study

(2011) Yishui Lian et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

MAGE-A family: Attractive targets for cancer immunotherapy

(2011) Meixiang Sang et al.   VACCINE

Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines

(2010) Shiqian Zhang et al.   BMC CANCER

Melanoma-associated antigen genes – An update

(2010) Meixiang Sang et al.   CANCER LETTERS

High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer

(2009) Alain Bergeron et al.   INTERNATIONAL JOURNAL OF CANCER